Allurion Technologies Inc. is ramping up its leadership team, supporting efforts to enter new markets with its Elipse Balloon , a nonsurgical gastric balloon intended to treat patients with obesity
The health care industry has witnessed many changes in the past 35 years or so since I began reporting on it, yet in some ways very little seems to have changed. While there has been enormous progress
The highly competitive global market for minimally invasive weight loss (bariatric) devices is predicted to rise from $137m in 2016 to $290m by 2021, a CAGR of 16%. This is driven in large part by the
Addressing a population of 600 million obese people worldwide, and a further 1 billion people overweight, the highly competitive global market for minimally invasive weight loss (bariatric) devices wa